1. Home
  2. BOLD vs IPM Comparison

BOLD vs IPM Comparison

Compare BOLD & IPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • IPM
  • Stock Information
  • Founded
  • BOLD 2018
  • IPM 2005
  • Country
  • BOLD United States
  • IPM United States
  • Employees
  • BOLD N/A
  • IPM N/A
  • Industry
  • BOLD
  • IPM
  • Sector
  • BOLD
  • IPM
  • Exchange
  • BOLD Nasdaq
  • IPM NYSE
  • Market Cap
  • BOLD 24.4M
  • IPM 27.9M
  • IPO Year
  • BOLD 2024
  • IPM N/A
  • Fundamental
  • Price
  • BOLD $1.19
  • IPM $2.01
  • Analyst Decision
  • BOLD Buy
  • IPM Strong Buy
  • Analyst Count
  • BOLD 3
  • IPM 1
  • Target Price
  • BOLD $4.00
  • IPM $6.00
  • AVG Volume (30 Days)
  • BOLD 105.1K
  • IPM 32.5K
  • Earning Date
  • BOLD 08-11-2025
  • IPM 08-13-2025
  • Dividend Yield
  • BOLD N/A
  • IPM N/A
  • EPS Growth
  • BOLD N/A
  • IPM N/A
  • EPS
  • BOLD N/A
  • IPM N/A
  • Revenue
  • BOLD N/A
  • IPM $6,344,746.00
  • Revenue This Year
  • BOLD N/A
  • IPM $1,957.49
  • Revenue Next Year
  • BOLD N/A
  • IPM $17.96
  • P/E Ratio
  • BOLD N/A
  • IPM N/A
  • Revenue Growth
  • BOLD N/A
  • IPM 14.16
  • 52 Week Low
  • BOLD $1.00
  • IPM $1.52
  • 52 Week High
  • BOLD $4.72
  • IPM $5.50
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • IPM N/A
  • Support Level
  • BOLD N/A
  • IPM N/A
  • Resistance Level
  • BOLD N/A
  • IPM N/A
  • Average True Range (ATR)
  • BOLD 0.00
  • IPM 0.00
  • MACD
  • BOLD 0.00
  • IPM 0.00
  • Stochastic Oscillator
  • BOLD 0.00
  • IPM 0.00

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About IPM INTELLIGENT PROTECTION MANAGEMENT

Intelligent Protection Management Corp is a communications software innovator that powers multimedia social applications.

Share on Social Networks: